Annual Interest Expense
N/A
March 31, 2024
Summary
- VTGN annual interest expense is not available.
Performance
VTGN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
September 30, 2024
Summary
- VTGN quarterly interest expense is not available.
Performance
VTGN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
September 30, 2024
Summary
- VTGN TTM interest expense is not available.
Performance
VTGN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
VTGN Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
VTGN Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
VistaGen Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $4000.00(>+9900.0%) | $4000.00(>+9900.0%) |
| Mar 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | - | $0.00(0.0%) | $1000.00(-75.0%) |
| Sep 2021 | - | $0.00(0.0%) | $4000.00(-60.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $10.00 K(-23.1%) |
| Mar 2021 | $13.00 K(-13.3%) | $1000.00(-66.7%) | $13.00 K(-23.5%) |
| Dec 2020 | - | $3000.00(-50.0%) | $17.00 K(+6.3%) |
| Sep 2020 | - | $6000.00(+100.0%) | $16.00 K(+14.3%) |
| Jun 2020 | - | $3000.00(-40.0%) | $14.00 K(0.0%) |
| Mar 2020 | $15.00 K(+87.5%) | $5000.00(+150.0%) | $14.00 K(+40.0%) |
| Dec 2019 | - | $2000.00(-50.0%) | $10.00 K(0.0%) |
| Sep 2019 | - | $4000.00(+33.3%) | $10.00 K(+11.1%) |
| Jun 2019 | - | $3000.00(+200.0%) | $9000.00(+50.0%) |
| Mar 2019 | $8000.00(-99.0%) | $1000.00(-50.0%) | $6000.00(+20.0%) |
| Dec 2018 | - | $2000.00(-33.3%) | $5000.00(+66.7%) |
| Sep 2018 | - | $3000.00(0.0%) | $3000.00(-99.9%) |
| Mar 2016 | $777.00 K | - | - |
| Dec 2015 | - | $3000.00(-89.3%) | $3.18 M(-20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $28.00 K(-96.2%) | $3.99 M(-13.1%) |
| Jun 2015 | - | $745.00 K(-69.0%) | $4.59 M(-0.5%) |
| Mar 2015 | $4.62 M(+195.6%) | $2.41 M(+195.7%) | $4.62 M(+68.9%) |
| Dec 2014 | - | $814.00 K(+29.6%) | $2.73 M(+18.6%) |
| Sep 2014 | - | $628.00 K(-18.2%) | $2.31 M(+13.5%) |
| Jun 2014 | - | $768.00 K(+46.6%) | $2.03 M(+29.9%) |
| Mar 2014 | $1.56 M(+55.6%) | $524.00 K(+36.1%) | $1.56 M(+12.0%) |
| Dec 2013 | - | $385.00 K(+9.1%) | $1.40 M(+5.4%) |
| Sep 2013 | - | $353.00 K(+17.3%) | $1.32 M(+8.7%) |
| Jun 2013 | - | $301.00 K(-15.4%) | $1.22 M(+13.3%) |
| Mar 2013 | $1.00 M(-47.0%) | $356.00 K(+13.7%) | $1.07 M(+49.6%) |
| Dec 2012 | - | $313.00 K(+26.7%) | $718.00 K(-16.5%) |
| Sep 2012 | - | $247.00 K(+56.3%) | $860.00 K(-19.1%) |
| Jun 2012 | - | $158.00 K(-65.3%) | $1.06 M(-35.0%) |
| Mar 2012 | $1.89 M | - | - |
| Dec 2011 | - | $455.00 K(+1.0%) | $1.64 M(+38.5%) |
| Sep 2011 | - | $450.50 K(-38.4%) | $1.18 M(+61.6%) |
| Jun 2011 | - | $731.60 K | $731.60 K |
FAQ
- What is the all time high annual interest expense for VistaGen Therapeutics?
- What is the all time high quarterly interest expense for VistaGen Therapeutics?
- What is the all time high TTM interest expense for VistaGen Therapeutics?
What is the all time high annual interest expense for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual interest expense is $4.62 M
What is the all time high quarterly interest expense for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly interest expense is $2.41 M
What is the all time high TTM interest expense for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM interest expense is $4.62 M